Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Search Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

Join us in New York

This exciting one-day seminar provides attendees with a unique opportunity to hear in-depth analysis of hot topics and trends concerning global biosimilars while engaging directly with Decision Resources Group analysts.

View the Agenda  |  Meet our expert speakers

Register

 


Recent Reports [ view all ]

  • Hepatitis C Virus: How Will More Efficacious Direct-Acting Antivirals Influence US Prescribing and Reimbursement for This Dynamic Indication?

    The primary goal of hepatitis C virus (HCV) treatment is to completely eliminate the virus from the patient’s body and... Read More

  • What Are the U.S. Market Access and Prescribing Hurdles for the Growing Number of LAMA- and LABA-Containing Competitors in the COPD Market?

    The U.S. market for chronic obstructive pulmonary disease (COPD) therapies consists entirely of symptomatic treatments,... Read More

  • Saudi Arabia: Market Access Tracker - 2014

    Last Updated 22 May 2014
    The Saudi pharmaceutical market is the largest market of the six Gulf... Read More

Decision Resources Group brands include: